FDA Panel Votes Retinal Prosthesis System Safe For Use

Monday, October 1, 2012

Ocular Surgery News

The U.S. Food and Drug Administration’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee voted 17-2 that there is a reasonable assurance the Argus II Retinal Prosthesis System is safe.

Full Story

If standard keratometry and biometry measurements are used to calculate the IOL power in a patient who has previously had myopic LASIK, the selected IOL power will most likely be too high.
1. True
2. False
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

FDA Panel Votes Retinal Prosthesis System Safe For Use

Comments

Quick Quiz

If standard keratometry and biometry measurements are used to calculate the IOL power in a patient who has previously had myopic LASIK, the selected IOL power will most likely be too high.

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

Smartphone-Based Retinal Screening System

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2